OnKure Therapeutics, Inc. OKUR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $59.05M-46.7% | $110.76M+271% | $29.88M+49.9% | $19.93M-84.0% | ||
| $5.67M+13.9% | $4.98M-64.2% | $13.92M-27.9% | $19.31M+12.6% | ||
| $60.84M-46.2% | $113M+235% | $33.77M-68.3% | $106.35M-30.8% | ||
| $618K-39.7% | $1.03M-28.4% | $1.43M+216% | $453K+114% | ||
| $387K-49.7% | $770K+61.1% | $478K-63.0% | $1.29M— | ||
| $273K+150% | $109K+87.9% | $58K-31.0% | $84K+7.7% | ||
| $62.12M-45.9% | $114.91M+222% | $35.73M-67.0% | $108.18M-29.8% | ||
| $1.43M-51.7% | $2.97M-13.1% | $3.42M+80.5% | $1.89M-6.4% | ||
| $549K+2.4% | $536K+158% | $208K-48.5% | $404K— | ||
| $5.92M-43.8% | $10.53M+44.5% | $7.29M+2.3% | $7.12M+14.9% | ||
| $549K-49.4% | $1.09M+61.0% | $674K-53.9% | $1.46M— | ||
| $12K— | —— | —— | —— | ||
| $5.93M-46.4% | $11.08M+42.9% | $7.75M-5.6% | $8.21M+20.5% | ||
| —— | —— | $0-100% | $3K0.0% | ||
| $270.42M+4.6% | $258.55M+123,609% | $209K-99.9% | $236.69M+2.1% | ||
| -$214.24M-38.5% | -$154.72M-51.6% | -$102.05M+25.3% | -$136.68M-61.3% | ||
| —— | —— | $8K+119% | -$43K-226% | ||
| $56.18M-45.9% | $103.83M+202% | -$101.84M-87.1% | -$54.42M-137% | ||
| $62.12M-45.9% | $114.91M+222% | $35.73M-67.0% | $108.18M-29.8% | ||
| $273K+150% | $109K+87.9% | $58K-31.0% | $84K+7.7% | ||
| $387K-49.7% | $770K+61.1% | $478K-63.0% | $1.29M— | ||
| $387K-49.7% | $770K+61.1% | $478K-63.0% | $1.29M— | ||
| $273K+150% | $109K+87.9% | $58K-31.0% | $84K+7.7% | ||
| $387K-49.7% | $770K+61.1% | $478K-63.0% | $1.29M— | ||
| $273K+150% | $109K+87.9% | $58K-31.0% | $84K+7.7% | ||
| $3.94M-43.9% | $7.03M— | —— | —— | ||
| —— | —— | $7K-75.9% | $29K-93.5% | ||
| $549K-49.4% | $1.09M+61.0% | $674K-53.9% | $1.46M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are OnKure Therapeutics, Inc.'s total assets?
- OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.
- How much debt does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.
- Can OnKure Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 13.78 — current assets exceed current liabilities.
- Where does OnKure Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.